Exactly my point, RAP isnt going to make money from research, its going to make money from proprietary technology isnt it? If I was a big tech company I would wait for some schmuck to do the research and hard yards, and just before (or after) FDA approval - I would send my resources to task to built competing software and infrastructure. Whats stopping RAP from being that schmuck?
To be clear - Im not down ramping, Im actually interested in RAP but I cant see how they are dealing with competitive risk - Id love to learn if they are because I really like what they are doing.
RAP - The Main Game, page-60
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?